SiBone (SIBN) Competitors $17.39 +0.36 (+2.11%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$17.38 -0.01 (-0.06%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SIBN vs. WRBY, LIVN, EYE, LMAT, LQDA, CNMD, ENOV, SSII, CDRE, and NVCRShould you be buying SiBone stock or one of its competitors? The main competitors of SiBone include Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), CONMED (CNMD), Enovis (ENOV), SS Innovations International (SSII), Cadre (CDRE), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. SiBone vs. Its Competitors Warby Parker LivaNova National Vision LeMaitre Vascular Liquidia Technologies CONMED Enovis SS Innovations International Cadre NovoCure Warby Parker (NYSE:WRBY) and SiBone (NASDAQ:SIBN) are both medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability. Do insiders and institutionals hold more shares of WRBY or SIBN? 93.2% of Warby Parker shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 18.2% of Warby Parker shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings and valuation, WRBY or SIBN? Warby Parker has higher revenue and earnings than SiBone. Warby Parker is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M3.20-$20.39M-$0.12-196.75SiBone$167.18M4.43-$30.91M-$0.64-27.17 Which has more risk and volatility, WRBY or SIBN? Warby Parker has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Is WRBY or SIBN more profitable? Warby Parker has a net margin of -1.79% compared to SiBone's net margin of -15.03%. Warby Parker's return on equity of -2.48% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-1.79% -2.48% -1.29% SiBone -15.03%-16.00%-11.69% Do analysts prefer WRBY or SIBN? Warby Parker presently has a consensus target price of $23.13, suggesting a potential downside of 2.05%. SiBone has a consensus target price of $22.50, suggesting a potential upside of 29.38%. Given SiBone's stronger consensus rating and higher probable upside, analysts plainly believe SiBone is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 9 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.53SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor WRBY or SIBN? In the previous week, Warby Parker had 12 more articles in the media than SiBone. MarketBeat recorded 14 mentions for Warby Parker and 2 mentions for SiBone. Warby Parker's average media sentiment score of 1.06 beat SiBone's score of 0.00 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryWarby Parker beats SiBone on 11 of the 16 factors compared between the two stocks. Get SiBone News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIBN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSiBoneMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$725.72M$6.76B$5.49B$9.52BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-27.1720.9428.7823.81Price / Sales4.4354.12372.2066.04Price / CashN/A20.5035.4557.96Price / Book4.374.468.275.54Net Income-$30.91M$174.54M$3.25B$259.28M7 Day Performance0.81%-5.27%-3.70%-4.64%1 Month Performance-5.64%-3.94%4.34%4.41%1 Year Performance17.90%8.26%25.90%17.95% SiBone Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSiBone3.7055 of 5 stars$17.39+2.1%$22.50+29.4%+17.2%$725.72M$167.18M-27.17350Positive NewsUpcoming EarningsHigh Trading VolumeWRBYWarby Parker2.0999 of 5 stars$24.10-1.2%$22.88-5.1%+48.9%$2.55B$771.32M-200.833,780News CoveragePositive NewsUpcoming EarningsAnalyst ForecastShort Interest ↑LIVNLivaNova2.9776 of 5 stars$43.46-0.5%$59.29+36.4%-14.9%$2.38B$1.25B-10.632,900News CoveragePositive NewsUpcoming EarningsEYENational Vision2.8527 of 5 stars$24.48-2.2%$23.00-6.0%+78.3%$1.98B$1.82B-74.1813,411Positive NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionLMATLeMaitre Vascular2.9929 of 5 stars$82.47+0.0%$97.83+18.6%-6.0%$1.86B$219.86M41.65490Upcoming EarningsLQDALiquidia Technologies3.3973 of 5 stars$19.82+1.1%$26.89+35.7%+52.5%$1.68B$14M-12.5450News CoverageUpcoming EarningsCNMDCONMED4.4135 of 5 stars$50.05-1.8%$62.20+24.3%-20.0%$1.58B$1.32B13.173,900News CoverageEarnings ReportAnalyst ForecastENOVEnovis2.9614 of 5 stars$27.36-0.7%$55.60+103.2%-44.7%$1.57B$2.11B-1.967,367Upcoming EarningsSSIISS Innovations InternationalN/A$7.20+0.3%N/AN/A$1.39B$20.65M0.004CDRECadre3.1541 of 5 stars$33.60-0.9%$37.50+11.6%-9.5%$1.38B$567.56M35.372,284Upcoming EarningsNVCRNovoCure4.4172 of 5 stars$11.64-3.3%$28.79+147.3%-47.1%$1.34B$605.22M-7.461,488News CoverageInsider Trade Related Companies and Tools Related Companies Warby Parker Competitors LivaNova Competitors National Vision Competitors LeMaitre Vascular Competitors Liquidia Technologies Competitors CONMED Competitors Enovis Competitors SS Innovations International Competitors Cadre Competitors NovoCure Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIBN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiBone Please log in to your account or sign up in order to add this asset to your watchlist. Share SiBone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIBN Stock Alerts